European Leukemia Trial Registry
Trial: CLBH589B2116

More Details
Title Dose-finding study of panobinostat plus Ara-C and mitoxantrone as salvage therapy for refractory or relapsed AML
Scientific Title A Phase Ib , open-label, multi-center dose-finding study of oral panobinostat (LBH589) in combination with a ara-C and mitoxantrone as salvage therapy for refractory or relapsed acute myeloid leukemia
Short Title CLBH589B2116
Trialgroup NN
Type of Trial multicentric, open-label
Disease Acute myeloid leukemia(AML) AML all subtypes without FAB M3
Age >= 18 years
Status No longer recruiting
Start of Recruitment 01.11.2009
Leader Ottmann, Prof. Dr., Oliver
Contactperson

principal investigator
Ottmann, Prof. Dr., Oliver
Tel: +49 (0)69 6301 87070
Fax: +49 (0)69 6301 4170
Email: ottmann@em.uni-frankfurt.de

Centre of Trial Universitätsklinikum Frankfurt
Shortprotocol Shortprotocol
created 19.11.2009 Irene Gleske
changed 01.06.2015 Hanna Ebert
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org